We are live on ! Find out more
E

Ergoteles Portfolio holdings

AUM $68.2M
1-Year Est. Return 36.16%
This Fund
S&P 500
This Quarter Est. Return
+13.32%
1 Year Est. Return
+36.16%
3 Year Est. Return
+76.43%
5 Year Est. Return
10 Year Est. Return
AUM
$2.72B
AUM Growth
-$123M
Cap. Flow
-$215M
Cap. Flow %
-7.9%
Top 10 Hldgs %
16.65%
Holding
2,200
New
704
Increased
294
Reduced
353
Closed
800

Sector Composition

Rank Sector Weight
1 Financials 15.28%
2 Healthcare 12.35%
3 Industrials 12.24%
4 Technology 10.34%
5 Consumer Discretionary 10.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TECX
1326
Tectonic Therapeutic
TECX
$564M
$33.4K ﹤0.01%
3,909
-5,237
-57% -$46.1K
LTCH
1327
DELISTED
Latch, Inc. Common Stock
LTCH
$33.1K ﹤0.01%
46,600
+31,436
+207% +$28.8K
LVOX
1328
DELISTED
LiveVox Holding, Inc. Class A Common Stock
LVOX
$33.1K ﹤0.01%
+11,134
New +$29.3K
IMDX
1329
Insight Molecular Diagnostics
IMDX
$152M
$33K ﹤0.01%
5,138
+1,923
+60% +$21.2K
QUMU
1330
DELISTED
Qumu Corp.
QUMU
$32.4K ﹤0.01%
+36,214
New +$27K
BGXX
1331
DELISTED
Bright Green Corporation Common Stock
BGXX
$29.6K ﹤0.01%
+63,075
New +$36.6K
VIRX
1332
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$28.9K ﹤0.01%
19,822
-112,814
-85% -$329K
TNYA icon
1333
Tenaya Therapeutics
TNYA
$166M
$28.7K ﹤0.01%
+14,261
New +$34.8K
APLT
1334
DELISTED
Applied Therapeutics
APLT
$27.8K ﹤0.01%
36,524
-15,161
-29% -$12K
BZFD icon
1335
BuzzFeed
BZFD
$102M
$26.3K ﹤0.01%
+9,521
New +$54.9K
VSTM icon
1336
Verastem
VSTM
$539M
$25.7K ﹤0.01%
5,323
-51,728
-91% -$254K
QNCX icon
1337
Quince Therapeutics
QNCX
$18.1M
$25K ﹤0.01%
+196
New +$32.8K
SLNO
1338
DELISTED
Soleno Therapeutics
SLNO
$24.9K ﹤0.01%
+12,570
New +$15.6K
NXTC icon
1339
NextCure
NXTC
$22M
$24.8K ﹤0.01%
+1,465
New +$33.7K
PEAR
1340
DELISTED
Pear Therapeutics, Inc. Class A Common Stock
PEAR
$24.1K ﹤0.01%
+20,438
New +$43K
TIL icon
1341
Instil Bio
TIL
$49.2M
$23.6K ﹤0.01%
+1,875
New +$92.7K
NXTT icon
1342
Next Technology
NXTT
$47.1M
$23.2K ﹤0.01%
+2
New +$68.7K
FUBO icon
1343
FuboTV Inc
FUBO
$264M
$23.1K ﹤0.01%
1,108
-70
-6% -$2.56K
LAB icon
1344
Standard BioTools
LAB
$309M
$21.4K ﹤0.01%
18,319
-178,578
-91% -$220K
ACHL
1345
DELISTED
Achilles Therapeutics
ACHL
$19.8K ﹤0.01%
+22,004
New +$37K
IMUX icon
1346
Immunic
IMUX
$183M
$19.6K ﹤0.01%
1,401
-1,072
-43% -$29.2K
SPPI
1347
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$18.9K ﹤0.01%
51,196
-330,706
-87% -$139K
STRM
1348
DELISTED
Streamline Health Solutions
STRM
$18.4K ﹤0.01%
+774
New +$18.8K
OPGN
1349
DELISTED
OpGen, Inc
OPGN
$18.2K ﹤0.01%
+644
New +$23.7K
AWRE icon
1350
Aware
AWRE
$24M
$18.1K ﹤0.01%
+10,557
New +$18.7K

Similar funds

Ergoteles's Q4 2022 Portfolio in Review

As of Q4 2022, Ergoteles held 2,200 positions worth $2.72B, down 4.3% from $2.85B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Ergoteles withdrew a net $215M in Q4 2022, closing 800 positions and reducing 353 holdings. Its most notable exit was Citrix Systems Inc, an estimated $149M position sold in full.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Ergoteles opened a new position in McKesson worth $43.9M.

  • Ergoteles's largest Q4 2022 buy was McKesson: 117,079 shares worth $43.9M.
  • Ergoteles added most to iShares Biotechnology ETF in Q4 2022, an estimated $85.8M increase.
  • Ergoteles's biggest Q4 2022 reduction was Alphabet (Google) Class C, cutting an estimated $41.8M.
  • Ergoteles fully exited Citrix Systems Inc in Q4 2022, selling an estimated $149M.
  • Ergoteles's ten largest holdings make up 17% of its $2.72B portfolio in Q4 2022.
  • Ergoteles opened 704 new positions and closed 800 in Q4 2022.
  • Ergoteles's portfolio value fell 4.3% quarter-over-quarter to $2.72B.

Based on Ergoteles's 13F filing for Q4 2022, filed 14 Feb 2023.